randomized controlled trials

You have accessRestricted Access
In Search of the Optimal Target for Phosphate Control: Episode 1
Ron Wald and Michael W. Walsh

JASN March 2021, 32 (3) 526-528; DOI: https://doi.org/10.1681/ASN.2021010027

Add to Selected Citations
You have accessRestricted Access
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study
Steven Fishbane, Mohamed A. El-Shahawy, Roberto Pecoits-Filho, Bui Pham Van, Mark T. Houser, Lars Frison, Dustin J. Little, Nicolas J. Guzman and Pablo E. Pergola

JASN March 2021, 32 (3) 737-755; DOI: https://doi.org/10.1681/ASN.2020081150

Add to Selected Citations
You have accessRestricted Access
Authors’ Reply
Tadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, Yoshikatsu Majikawa and Michael Reusch

JASN November 2020, 31 (11) 2738-2740; DOI: https://doi.org/10.1681/ASN.2020071096

Add to Selected Citations
You have accessRestricted Access
Pilot Trials in Nephrology: Establishing a BASE for Large-Scale Randomized Trials
Brendon L. Neuen and Vlado Perkovic

JASN January 2020, 31 (1) 4-6; DOI: https://doi.org/10.1681/ASN.2019111196

Add to Selected Citations
You have accessRestricted Access
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials
Lesley A. Inker, Hiddo J. L. Heerspink, Hocine Tighiouart, Andrew S. Levey, Josef Coresh, Ron T. Gansevoort, Andrew L. Simon, Jian Ying, Gerald J. Beck, Christoph Wanner, Jürgen Floege, Philip Kam-Tao Li, Vlado Perkovic, Edward F. Vonesh and Tom Greene

JASN September 2019, 30 (9) 1735-1745; DOI: https://doi.org/10.1681/ASN.2019010007

Add to Selected Citations
You have accessRestricted Access
The Case for Selective Withdrawal of Antidepressants in Patients with Advanced Kidney Disease
Joseph Chilcot and Ken Farrington

JASN July 2019, 30 (7) 1339-1340; DOI: https://doi.org/10.1681/ASN.2019030308

Add to Selected Citations
You have accessRestricted Access
Dual Inhibition of Gastrointestinal Phosphate Absorption: More Questions Than Answers
Wing-Chi G. Yeung, Nigel D. Toussaint and Sunil V. Badve

JASN June 2019, 30 (6) 909-910; DOI: https://doi.org/10.1681/ASN.2019040333

Add to Selected Citations
Open Access
Persistent Underrepresentation of Kidney Disease in Randomized, Controlled Trials of Cardiovascular Disease in the Contemporary Era
Rohit Maini, David B. Wong, Daniel Addison, Elizabeth Chiang, Steven D. Weisbord and Hani Jneid

JASN December 2018, 29 (12) 2782-2786; DOI: https://doi.org/10.1681/ASN.2018070674

Add to Selected Citations
Open Access
Translational Methods in Nephrology: Individual Treatment Effect Modeling
F. Perry Wilson and Chirag R. Parikh

JASN November 2018, 29 (11) 2615-2618; DOI: https://doi.org/10.1681/ASN.2018060629

Add to Selected Citations
You have accessRestricted Access
Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial
Christoph Wanner, Hiddo J.L. Heerspink, Bernard Zinman, Silvio E. Inzucchi, Audrey Koitka-Weber, Michaela Mattheus, Stefan Hantel, Hans-Juergen Woerle, Uli C. Broedl, Maximilian von Eynatten, Per-Henrik Groop and on behalf of the EMPA-REG OUTCOME Investigators

JASN November 2018, 29 (11) 2755-2769; DOI: https://doi.org/10.1681/ASN.2018010103

Add to Selected Citations

Main menu

User menu

Search

randomized controlled trials

Pages

Articles

Information for Authors

About

Journal Information

More Information